Free tool · nothing to sign up for
Schedule M of the Drugs and Cosmetics Rules was replaced by G.S.R. 922(E), notified on 28 December 2023. Six Parts became thirteen. This page answers the four questions that decide how much work a site is facing: which Parts apply, what is built once for the whole site, which workstream is blocking which, and what goes into the Product Quality Review.
G.S.R. 922(E)
Six before, Part I common to all
Hazardous, biological, radio, phyto, trial
Every product, exports included
The rule that decides everything below: the specific Parts are additive, not alternative. Each one opens by requiring the main principles of Part I to be complied with, mutatis mutandis. Where two specific Parts apply, both apply, and the more demanding requirement governs.
Part I applies to every licensed manufacturer without exception, so it is not repeated on each card. Capital intensity and elapsed time are this site's judgement for a site starting from the 2001 Schedule, not figures published by the authority.
What decides whether this succeeds
Documenting and justifying where GMP begins in the synthetic route (Part XII, para 1.2). Every downstream decision follows from that one line.
Most often found open at inspection
Reserve samples too small for two full analyses; retest date not supported by stability data.
Capital intensity: Medium · realistic elapsed time: 9–14 months
What decides whether this succeeds
Demonstrated effectiveness of cross-contamination control, not merely the presence of dust extraction (paras 18.11–18.12).
Most often found open at inspection
Cleaning limits carried over from a 1/1000th-dose rule with no health-based justification.
Capital intensity: Low–Medium · realistic elapsed time: 8–12 months
What decides whether this succeeds
Purified Water IP system integrity, and per-container DEG and EG testing of every glycol consignment by a validated method.
Most often found open at inspection
Accepting the supplier certificate for glycerine or propylene glycol without in-house testing of every container.
Capital intensity: Medium · realistic elapsed time: 8–12 months
What decides whether this succeeds
The filter train on recirculated air — primary, secondary and tertiary (for example G4 + F8 + H13). The 2001 text asked only for 20 micron filtration.
Most often found open at inspection
The existing AHU fan cannot develop the static pressure an H13 filter needs. Found late, it becomes the critical path.
Capital intensity: Medium · realistic elapsed time: 8–12 months
What decides whether this succeeds
One contamination control strategy tying together classification, continuous particle monitoring, airflow visualisation, media fills, gowning qualification and qualified visual inspectors.
Most often found open at inspection
Media fills that leave out the worst-case interventions actually performed; no smoke study; no eyesight records for visual inspectors.
Capital intensity: High · realistic elapsed time: 12–24 months
What decides whether this succeeds
Terminal sterilisation validated on the real maximum and minimum load patterns, with F0 mapping and container leak testing.
Most often found open at inspection
A steriliser validated on an empty chamber rather than on the loads actually run.
Capital intensity: High · realistic elapsed time: 12–24 months
What decides whether this succeeds
Loading and unloading protected under Grade A, with lyophiliser sterilisation-in-place and leak rate trended.
Most often found open at inspection
A media fill run without simulating the lyophilisation hold under partial vacuum.
Capital intensity: Very high · realistic elapsed time: 18–30 months
What decides whether this succeeds
Classify the product first. Schedule M has no implant Part. A drug implant sits here; an implantable device is governed by the Medical Devices Rules 2017 and Schedule M does not apply to it at all.
Most often found open at inspection
Running a Schedule M programme on a product regulated as a device — and so omitting design controls, risk management to ISO 14971 and post-market surveillance entirely.
Capital intensity: Very high · realistic elapsed time: 18–30 months
What decides whether this succeeds
Capturing all four data sets Part XI, para 9 requires — area temperature and humidity, periodic filled weights, check-weigher rejections, spray-test rejections.
Most often found open at inspection
Three of the four present, and spray-test rejections not recorded at all.
Capital intensity: High · realistic elapsed time: 12–18 months
What decides whether this succeeds
Cell bank and seed lot governance with storage split across more than one location, containment matched to the biosafety level, and a rapid alert route for recall.
Most often found open at inspection
Cell banks held in a single location; no documented rapid-alert link to the licensing authority.
Capital intensity: Very high · realistic elapsed time: 18–36 months
What decides whether this succeeds
A documented release strategy that separates pre-release testing from retrospective testing, justified product by product.
Most often found open at inspection
The retention sample exemption applied as a blanket policy rather than justified for each product.
Capital intensity: Very high · realistic elapsed time: 18–30 months
What decides whether this succeeds
Botanical authentication and contaminant control on a naturally variable raw material, and correct designation of added substances against the genuine extract.
Most often found open at inspection
A specification with no pesticide, heavy metal or aflatoxin limits.
Capital intensity: Medium · realistic elapsed time: 10–15 months
What decides whether this succeeds
Containment as a verified engineered system serving three objectives at once: product quality, operator protection and environmental protection.
Most often found open at inspection
An AHU shared with non-hazardous production, and containment demonstrated by design intent rather than by performance data.
Capital intensity: Very high · realistic elapsed time: 15–30 months
What decides whether this succeeds
Para 18.11 requires a dedicated, self-contained facility. This is not a shared-facility option under any cleaning regime.
Most often found open at inspection
Attempting to justify shared equipment through cleaning validation.
Capital intensity: High · realistic elapsed time: 12–24 months
What decides whether this succeeds
The Product Specification File, and blinding control. Both are new concepts for most Indian formulation sites.
Most often found open at inspection
Destruction of returned supplies logged as a stock movement instead of a documented destruction with a certificate to the sponsor.
Capital intensity: Low–Medium · realistic elapsed time: 6–10 months
What decides whether this succeeds
There is no Part for these. Apply Part I in full, then reason your way to the closest specific Part and record the reasoning. That applicability determination is itself an inspectable record under the quality risk management requirement.
Most often found open at inspection
Either ignoring the question, or over-applying a sterile package to a product that does not need one.
Capital intensity: Varies · realistic elapsed time: Varies
Most of the implementation effort is the same whatever you make. The mistake that wastes the most money is running a separate compliance project for each product category.
Shared across the whole site — build once
Layer 1 — Quality governance
Pharmaceutical quality system, quality risk management, change control, deviation and CAPA, self-inspection, management review, the framework for the Product Quality Review.
Layer 2 — The infrastructure of records
Document control, good documentation practice, computerised systems, access control, audit trail review, backup and restoration.
Layer 3 — Common operations
Materials and supply chain, supplier qualification, training, warehouse conditions, calibration, maintenance, waste, complaints and recall, the Site Master File.
Layer 4 — Shared utilities
Purified water, HVAC, compressed air, steam — qualified once, to the acceptance criteria of the most demanding category they serve.
Layer 5 — multiplies per category, and this is where the capital and the specialists sit
Sterile and injectable
Classification, environmental monitoring, media fills, smoke studies, WFI, visual inspection.
Oral solid
Dust control, leak testing, isolated beta-lactam packing.
Oral liquid
Purified Water IP, DEG and EG per container, hold times.
Topical
Filter train G4 + F8 + H13, exhaust, airlocks.
API, potent, biological
GMP starting point, containment, cell banks.
A site making tablets, syrups and creams needs one quality system, one change control system, one supplier qualification programme and one purified water system — qualified to the criteria of the most demanding of the three. It needs three contamination control strategies and three sets of category validation. Planned that way it is one programme with three workstreams. Planned per category it is three programmes that each rebuild the same core.
Schedule M is organised by subject — personnel, premises, equipment, materials — because that is how a reference text has to be organised. It is the wrong order to work in, because the requirements depend on each other and those dependencies cross departmental boundaries. Here the same content sits in ten workstreams.
Costs time, not capital. Nothing gates these.
WS1 · lead: QA · Part I — 1, 2, 3, 8, 10
Cannot start until: Nothing. This starts in week one.
Its absence blocks: Everything. No workstream closes out without change control and risk management running.
The quality system is not a QA document. Para 1.2 puts ultimate responsibility on senior management and requires roles defined across the whole organisation. A manual signed only by QA does not satisfy it.
WS2 · lead: IT with QA · Part I — 17, 20
Cannot start until: Change control must exist before you reconfigure any system.
Its absence blocks: The credibility of every QC release, the Product Quality Review, and any validation whose raw data sits on an instrument.
Para 20.4 sits in the quality assurance chapter but is delivered by IT, on instruments owned by QC, and on systems owned by engineering. In most sites an analyst still holds administrator rights on the chromatography system — so the control does not exist, whatever the software can do.
WS3 · lead: Engineering · Part I — 12, 14.12; Parts II, III, IX, X, XII
Cannot start until: Capital approval, and usually a shutdown window.
Its absence blocks: Equipment qualification, process validation, environmental monitoring — and therefore batch release.
HVAC is specified in the premises chapter, monitored under quality control, qualified by engineering and paid for by finance. It is also the longest lead item, so it has to start before the documentation looks ready.
WS5 · lead: SCM with QA · Part I — 1.5(f), 10.6, 10.7, 14, 19.7
Cannot start until: The approval workflow from WS1.
Its absence blocks: Production start-up after any vendor change, and element (a) of the Product Quality Review.
Supplier audit is written into the self-inspection chapter, executed by QA, contracted by procurement and verified by QC testing. Procurement targets on price conflict directly with the duty to buy from the qualified producer rather than a trader. That conflict is settled at management level, not at QA level.
WS8 · lead: HR with QA · Part I — 4, 11; Part II — 7
Cannot start until: The role and responsibility definitions from WS1.
Its absence blocks: Aseptic operations entirely. An unqualified gowning operator cannot enter Grade B.
Job descriptions are an HR artefact carrying statutory GMP content. Aseptic gowning qualification is HR-recorded, QA-approved, microbiology-tested and production-executed.
Cannot start early, however much pressure there is.
WS4 · lead: Engineering with QA · Part I — 5, 13; every specific Part
Cannot start until: The facility being complete, and WS2 for any computerised equipment.
Its absence blocks: Commercial manufacture of any affected product, and element (k) of the Product Quality Review.
The validation master plan is a QA document, executed by engineering, on production equipment, with QC analytical support, using IT-validated data systems. Four functions, one deliverable.
WS7 · lead: QC · Part I — 15, 19
Cannot start until: WS2 for instrument data integrity; WS3 for chamber utilities and back-up power.
Its absence blocks: Release, shelf-life justification, and element (g) on stability trends.
The on-going stability programme needs a qualified chamber, continuous monitoring with alarms, validated methods and trend evaluation feeding the review. Engineering, IT, QC and QA, for one requirement.
WS6 · lead: Production · Part I — 18; Parts VIII to XIII
Cannot start until: The pressure cascade from WS3, and cleaning validation from WS4.
Its absence blocks: Multi-product operation and campaign changeover.
Para 18.11 lists technical and organisational measures. Engineering supplies the airlocks and pressure differentials, production supplies the campaign discipline, QA supplies the cleaning validation. Any one of the three failing makes the other two worthless.
Where an inspector looks to judge the rest.
WS9 · lead: QA · Part I — 2.3, 10, 19.8
Cannot start until: Data being retrievable (WS2), qualification status (WS4), stability data (WS7).
Its absence blocks: Nothing operationally — but its absence is a certain finding, and it is the mechanism by which every other workstream is verified.
The most cross-functional requirement in the Schedule. Its twelve mandatory elements draw on materials, in-process and finished results, deviations, changes, dossier variations, stability, complaints and recalls, equipment and utility qualification status, and technical agreements. No single function can produce it.
WS10 · lead: QA with regulatory affairs · Part I — 6, 7; Part IV — 17
Cannot start until: Distribution records retrievable to retail level.
Its absence blocks: Nothing until it is needed — at which point it blocks everything.
Para 7.5 requires informing the licensing authority of an intention to recall. That is a regulatory affairs action, triggered by a QA decision, on evidence held by QC, executed through a commercial distribution network.
The Product Quality Review (Part I, para 2.3) is new, mandatory, annual, and required for every product — including products made only for export. Inspectors read it early, because it is the fastest way to judge whether a quality system is real. Its twelve elements draw data from six functions, which is why a review assembled by QA alone, from whatever data it could find, reads as thin.
| # | Element | Where the data lives |
|---|---|---|
| a | Starting and packaging materials, including supply-chain traceability for actives | Supply chain |
| b | Critical in-process controls and finished product results | QC |
| c | All batches that failed specification, and their investigations | QC and QA |
| d | Significant deviations, their investigations, and CAPA effectiveness | QA |
| e | All changes to processes or analytical methods | QA |
| f | Dossier variations submitted, granted or refused | Regulatory affairs |
| g | Stability monitoring results and any adverse trend | QC |
| h | Quality-related returns, complaints and recalls | QA and commercial |
| i | Adequacy of previous corrective actions | QA |
| j | Post-marketing commitments for new dossiers and variations | Regulatory affairs |
| k | Qualification status of equipment and utilities — HVAC, water, gases | Engineering |
| l | Currency of technical agreements | Legal and QA |
Para 2.3.3 closes the loop. The results must be evaluated, an assessment made of whether corrective action or revalidation is required, the actions completed in a timely and effective manner — and their effectiveness verified during self-inspection. A review that ends at observation, with no action and no later verification, does not meet the requirement. Grouping by product type is permitted only where scientifically justified, and the authorised person responsible for batch certification must ensure the review is timely and accurate.
Prepared from the gazette text of G.S.R. 922(E) as a working aid. It is not legal advice, and where anything here differs from the gazette, the gazette governs. Check the current text and any later amendment with CDSCO or your state licensing authority before acting on it.
